Nov 23, 2020
21:20
For every 20 shares held, investors received 21. The price per share adjusted from $208.00 to $198.10.
The split itself did not change the total investment value.
Square Pharmaceuticals PLC (DSE:SQURPHARMA) operates in the Pharmaceuticals: major industry.
Square Pharmaceuticals PLC company overviewSquare Pharmaceuticals PLC's most recent stock split was on November 23, 2020. It was a 21-for-20 forward split, so shareholders received 21 shares for every 20 they held.
Square Pharmaceuticals PLC (DSE:SQURPHARMA) has split its stock 10 times: a 10-for-1 split on December 4, 2011, a 7-for-5 split on August 27, 2012, a 13-for-10 split on August 27, 2013, a 23-for-20 split on August 27, 2014, a 9-for-8 split on August 16, 2015, a 11-for-10 split on November 15, 2016, a 43-for-40 split on November 9, 2017, a 107-for-100 split on November 28, 2018, a 107-for-100 split on November 20, 2019, and a 21-for-20 split on November 23, 2020.
Square Pharmaceuticals PLC has split its stock 10 times. This history records 10 forward splits between December 4, 2011 and November 23, 2020.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Square Pharmaceuticals PLC's 21-for-20 split on November 23, 2020, every 20 shares became 21 shares.
Square Pharmaceuticals PLC has not announced a new split in our records. Its most recent split was on November 23, 2020, 5 years ago. Companies announce splits in advance, and any new DSE:SQURPHARMA split will appear on this page.
Already premium?